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Passiflora edulis Sims together with several other plants of the genus Passiflora have been reported to possess
anxiolytic properties. It has been suggested recently that flavonoids may be partly responsible for the
neuropharmacological activity of these plants but there are still few data reporting the relation between
the constituents of these plants and their activity. This work evaluated the anxiolytic/sedative activity of an
aqueous extract of Passiflora edulis Sims and bioguided its fractionation using the elevated plus-maze model
of anxiety and other complementary pharmacological tests. The aqueous extract presented an anxiolytic-like
activity without any significant effect upon the motor activity whilst the total flavonoid fraction (TFF) pre-
sented an anxiolytic-like activity but compromised motor activity. Through fractionation of TFF it was possi-
ble to isolate and characterize luteolin-7-O-[2-rhamnosylglucoside] which showed an anxiolytic-like activity
without compromising motor activity. Copyright © 2006 John Wiley & Sons, Ltd.
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to be used in Brazilian traditional folk medicine (Maluf
et al., 1991; Vale and Leite, 1983) and to be active
in animal models of anxiety (Petry et al., 2001). This
plant is widely available in Portugal as a garden plant
or a crop and previous work by some members of our
group showed that P. edulis Sims aqueous extracts
had significant affinity for 5-HT3 rat brain receptors
thus suggesting an eventual anxiolytic activity (Cotrim
et al., 1995). As it has been suggested that flavonoids
may play a role in the neuropharmacological activity of
several plants (Medina et al., 1997; Paladini et al., 1999)
including P. incarnata L. (Zanoli et al., 2000) and
P. coerulea L. (Wolfman et al., 1994) we wanted to
establish if the aqueous extract of Passiflora edulis Sims
growing in Portugal and the flavonoids it contains had
any activity in classical animal models of anxiety using
properly characterized extracts and also to isolate and
identify those flavonoid constituents possibly involved
in this activity.
Two non-conditioned tests were chosen that are well
accepted for determining the anxiolytic-like activity
of these preparations in mice: the elevated plus-maze
(EPM) (Lister, 1987; Rodgers and Cole, 1994; Rodgers
and Dalvi, 1997) and the marble-burying test (MBT)
(Broekkamp et al., 1986). To evaluate any eventual
effects on motor activity the wire test (Boissier et al.,
1961) and the chimney test (Boissier et al., 1960) were
chosen.
INTRODUCTION
Passiflora incarnata L. is the one Passifloraceae most
commonly used in Europe for its anxiolytic/sedative
properties and is referred to as the medicinal species
in different official publications (ESCOP, German
Commission E Monographs). Despite this fact there have
been several reports over the years on the anxiolytic/
sedative activity of various other species of the genus
Passiflora, namely P. edulis Sims (Petry et al., 2001), P.
coerulea L. (Wolfman et al., 1994), P. alata Curtis (Oga
et al., 1984). These studies carried out with different
animal models generally show insufficient characteriza-
tion of the extracts and/or botanical materials used
and this has brought some controversy on which of
the Passiflora genus species do possess any neurop-
harmacological activity and which are the active
constituents involved in it (Dhawan et al., 2004).
Passiflora edulis Sims is the edible variety most
commonly known for its tasty fruit but also reported
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either a 5 mm reverse detection (1H-NMR, HMBC and
COSY) or a 5 mm broadband probe (13C-NMR).
Acid hydrolysis of compounds A and B was per-
formed (Markham, 1989) and the genin was analysed
by HPLC and co-chromatographed with standard
luteolin and orientin, purchased from Extrasynthése
(Genay, France).
Pharmacological assays. Adult male Swiss mice (25–
35 g) were used. Animals were housed in a local animal
house in groups of ten animals per plastic cage, with a
controlled dark/light 12 h cycle (lights on at 07:00 h)
and food was supplied ad libitum. Each animal was used
just once. All experiments were conducted in accord-
ance with international standards of animal welfare
recommended by the Brazilian Society of Neuroscience
and Behavior (Act 1992) and the experimental pro-
tocols were approved by the University Committee
for Animal Care in Research (#23080.001156/2001-50/
UFSC). The minimum number of animals and the
duration of observation required to obtain consistent
data were used.
The animals were orally administered, using an
intragastric cannula (by gavage), with the different test
solutions, diazepam or distilled water (vehicle) 60 min
before testing. To ascertain the best time-course for
observation, the infusion and TFF were previously
tested with 30, 60, 90 and 120 min delays before the
testing. On the test day, mice were placed in the labo-
ratory 1 h prior to the experiment, which was always
conducted during the same period of the day (09.00–
13.00 h). The lyophilized infusion was restored with
water immediately before testing and doses were evalu-
ated in the range between 14.4 and 230 mg/kg. TFF, SF
(I, II, III), A and B were also dissolved in distilled
water and tested in doses corresponding to its percent-
age in the extract from which they were obtained.
Complementary doses ranging from 1 to 100 mg/kg were
also tested. Diazepam was used in a dose of 1 mg/kg
and extemporaneous solutions were prepared by slowly
diluting a commercial diazepam formulation (Valium®
Roche/5 mg) in distilled water immersed in an ultra-
sound bath.
Elevated plus-maze test (EPM). The elevated plus-maze
was slightly modified from that used by Lister (1987).
Briefly, it consisted of two open arms (30 × 5 × 0.25 cm)
and two enclosed arms (30 × 5 × 15 cm), extending
from a central platform (5 × 5 cm) and arranged so that
two pairs of identical arms were opposite to each other.
The apparatus was raised to a height of 50 cm above
floor level. The maze floor was constructed from black
Plexiglas and the walls from clear Plexiglas. At the
beginning of the test, each mouse was placed on the
central platform facing an enclosed arm. After the test
(5 min), the maze was carefully cleaned with wet tissue
paper (10% ethanol solution). Mouse behaviour was
recorded under red light illumination (15 W) by using a
video-camera located 100 cm above the maze. Tapes
were analysed ‘blind’ for the treatment used. The
conventional spatiotemporal measures were the number
of entries (all four paws on open or enclosed arms
and expressed as the percentage of total entries), the
time spent on open arms (expressed as the percentage
of time spent on closed plus open arms), number of
entries on enclosed arms and the time on the central
METHODS
Plant material. Leaves from plants growing wild in Beira
Litoral, Portugal, were used. The leaves were collected
during the flowering season, dried in a flow of hot
air (25 °C), ground and stored below −10 °C. A pro-
perly identified voucher specimen of the starting plant
material, Passiflora edulis Sims, was deposited in the
Botanical Institute, University of Coimbra and refer-
enced by the author’s name.
Flavonoids extraction and fractionation. A 6% (w/v)
infusion was prepared by adding boiling water to the
powder sample. The filtered infusion was stirred, for
1 h with Amberlite XAD 2 (BDH Laboratory Reagents)
and the phenolic compounds fixed in this resin were
eluted with MeOH and 75% MeOH. Both eluates were
mixed and concentrated to dry residue, which was
re-dissolved in 75% MeOH and chromatographed
on Sephadex LH-20 (Sigma, 25–100 µm). All fractions
collected were monitored by TLC (silica gel), EtOAc/
HCOOH/H2O, 9:1:1, detection under UV354nm before
and after the action of ammonia vapour and after
spraying with the reagent NEU/PEG (Markham, 1989).
Fractions exhibiting the typical flavonoid profile were
pooled and concentrated to dryness resulting in the total
flavonoid fraction (TFF).
The TFF was chromatographed on Whatman 3 mm
paper, EtOAc/HCOOH/H2O, 44:16:20. The three
distinct absorption bands observed under UV354nm were
cut out and eluted with 50%–100% MeOH to yield
three flavonoid subfractions: SF I, SF II and SF III. SF
I was subsequently chromatographed on Whatman®
3 mm paper, HOAc 15% and the two distinct UV354nm
absorption bands (compounds A and B) were cut out
and eluted with MeOH. The residue of these eluates
was dissolved in water and purified with Isolute® C18
pre-packed columns.
Analytical procedures. The composition of the infusion,
TFF, SF I, SF II, SF III, A and B was analysed by
HPLC using a Gilson® apparatus, a reverse phase
column (250 × 4 mm; Spherisorb® S5 ODS 2) and a
Nucleosil® C18 pre-column (particle size 5 µm; 30 ×
4 mm). Gradient 1: linear gradient of MeOH/5%
HCOOH (35% to 80% in 60 min) with a flow rate of
1 mL/min. Gradient 2: water (pH = 2.2 with H3PO4)
(A)/acetonitrile (B) (0–12 min: 100%–91% of A;
12–20 min: 91%–87% of A; 20–40 min: 87%–67% of
A; 40–42 min: 67% of A; 42–52 min: 67%–57% of A;
52–60 min: 57% of A) with a flow of 0.8 mL/min. Peak
detection and absorption spectra were obtained with a
Gilson® ‘170 diode array detector’ (Campos et al., 1997).
The infusion and the TFF were screened for the pres-
ence of tannins and alkaloids. For tannins TLC (silica
gel) was used with CHCl3/EtOAc/HCOOH, 5:4:1, de-
tection with 5% phosphomolybdic acid in MeOH after
heating at 80 °C during 10 min. For alkaloid screening
the procedure recommended by French Pharmacopoeia
X was followed. The flavonoid contents of the different
fractions were determined according to the Passiflora
incarnata L. monograph in French Pharmacopoeia X.
NMR spectra of the two isolated compounds and
their hydrolysates (dissolved in 600 µL DMSO-d6) were
recorded in a Varian Unity-500 spectrometer using
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platform. Ethologically derived measures were groom-
ing, rearing, stretched attend postures (SAP), head-
dipping (HD) and defaecation as an emotionally
related parameter (Rodgers and Dalvi, 1997; Espejo,
1997). A selective increase in the spatiotemporal
parameters of exploration of the open arms of the maze
reveals an anxiolytic-like effect (Pellow et al., 1985).
Marble-burying test (MBT). This test consisted of
a Plexiglas cage of 23 × 17 × 14 cm with a smooth
lid punctured by small ventilation holes. The floor
was covered with a 5 cm layer of sawdust and 25 glass
marbles were placed in contact with each other in the
centre of the maze. The mouse was placed in the cage
for 30 min after which it was removed and the burying
response quantified by counting the number of marbles
that were more than two thirds covered with sawdust.
A diminution of the burying reflex reveals a positive
anxiolytic-like effect (Broekkamp et al., 1986).
Motor performance evaluation. Muscle relaxant effects
were evaluated using the horizontal-wire test which
consisted of a stretched copper wire placed 20 cm above
the ground (Boissier et al., 1961). The animal is
suspended in the wire by its fore paws and the time
taken for the animal to reach the wire with the hind
paws or tail is counted. Animals who failed to do it
within 5 s were considered to have failed the test and
this was considered to be synonymous with muscle
relaxation (Vogel and Vogel, 1997).
Motor coordination was assessed using the chimney
test which consisted of a simple glass tube in which the
experimental mouse entered and when it reached the
other end, the tube was placed in a vertical position.
The normal reaction of the animal was to climb the
tube backwards. Animal performance was evaluated by
the time taken to reach the upper edge of the glass
tube considering motor impairment the inability of
the mouse to climb backwards up the tube within 30 s
(Boissier et al., 1960).
Statistical analysis. Statistical analysis of the results
obtained was done with GraphPad Instat® software,
using ordinary ANOVA followed by post-hoc Tukey’s
test for comparisons between treatments and Fisher’s
exact test for the Horizontal-wire and chimney tests.
Differences between the experimental groups were con-
sidered statistically significant when p < 0.05.
RESULTS
Flavonoid extraction and analytical procedures
Infusions of Passiflora edulis Sims leaves were found to
contain 2.45 ± 0.1% (w/w) of flavonoids expressed in
rutin. The TLC control of the fractionation process on
Sephadex LH-20 revealed the presence of a majority
of compounds with strong UV354nm absorption, yellow/
greenish fluorescence after exposure to ammonia
vapour and yellow/orange fluorescence after revelation
with NEU/PEG thus suggesting a flavone type struc-
ture (Markham, 1989). This fractionation procedure
yielded 1.4 ± 0.3% (w/w) of TFF which presented a
flavonoid content of 60 ± 0.2% (w/w). Tannin screening
Figure 1. Schematic representation of a total flavonoid fraction
(TFF) HPLC chromatogram (Gradient 2; detection: 340 nm),
signalling each sub-fraction (SF I, II and III) constituents
obtained after preparative paper chromatography (PC) of TFF.
was positive for the infusion but negative for TFF.
Alkaloids were absent from the infusion as well as from
TFF.
Preparative PC of TFF yielded three sub-fractions:
SF I [17.3% (w/w)], SF II [51.8% (w/w)] and SF III
[11.4% (w/w)] and their HPLC profiles were established
(Fig. 1). The different chromatograms (HPLC, PC) of
SF I have shown that it was composed of two com-
pounds: A [retention time (Rt) = 37.4 min (gradient 2)
and Rt = 9.4 min (gradient 1)] and B (Rt = 34.5 min
(gradient 2) and Rt = 10.8 min (gradient 1). PC of SF I
with HOAc 15% allowed the isolation of compound A
[20.3% (w/w); retention factor (Rf) = 0.29] and com-
pound B [72.1% (w/w); Rf = 0.58]. After acid hydroly-
sis, A presented the same Rt (gradient 1 = 28.1 min;
gradient 2 = 49.5 min), Rf (PC/HOAc 70%: 0.56) and
UV spectrum (absorption maxima: 245sh, 254, 267,
291sh, 349 nm) as standard luteolin. After acid hydroly-
sis B presented the same Rt (gradient 1: 9.4 min; gradi-
ent 2: 34.9 min) and Rf (PC/HOAc 15%: 0.15) as pure
standard orientin and its UV absorption maximums
were also superimposable (255, 266, 292sh, 348 nm).
NMR analysis of compounds A and B
Compound A – 1H-NMR (500 MHz, DMSO-d6): δ
(ppm) = 7.45 (1H, d, J = 2.2 Hz, H-6′), 7.40 (1H, s,
H-2′), 6.90 (1H, d, J = 8.4 Hz, H-5′), 6.77 (2H, s, H-3,
H-8), 6.37 (1H, d, H-6), 5.24 (1H, d, J = 7.3 Hz,
H-1Glc), 5.13 (1H, s, H-1 Rha). After hydrolysis: 7.42
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Table 1. Time course of the behavioural effects tested in the EPM
30 min 60 min 90 min 120 min
Plus-maze Plus-maze Plus-maze Plus-maze
%OE %OT %OE %OT %OE %OT %OE %OT
Vehicle 21.3 ± 5.8 19.4 ± 8.6 18.3 ± 4.5 16.3 ± 6.6 14.5 ± 10.5 13.6 ± 11.1 20.8 ± 6.7 14.2 ± 10.2
Diazepam 25.5 ± 13.4 30.3 ± 16.5 49.9 ± 14.7b 54.8 ± 12.8b 44.8 ± 17.6a 47.8 ± 19.8a 33.9 ± 16.8 43.2 ± 15.0a
TFF 22.5 ± 16.4 14.6 ± 9.3 43.4 ± 16.5a 40.1 ± 12.1b 39.4 ± 12.2a 37.3 ± 8.4b 29.6 ± 12.4 34.3 ± 14.4
Infusion 30.3 ± 9.5 23.4 ± 7.5 36.9 ± 9.3a 35.3 ± 10.1a 29.8 ± 4.3a 25.1 ± 5.2 30.1 ± 7.4 14.5 ± 12.3
Behavioural effects 30, 60, 90 and 120 min after administration of vehicle, diazepam, TFF and infusion.
%OE, % number of entries in the open areas of the plus-maze vs total number of entries; %OT, % time spent in the open areas of
the plus-maze. Data presented as mean ± SEM. Statistical analysis, a p < 0.05, b p < 0.001 with ANOVA and Tukey’s test.
(1H, s, H-2′), 7.39 (1H, d, J = 2.3 Hz, H-6′), 6.88 (1H, d,
J = 8.4 Hz, H-5′), 6.67 (1H, s, H-3), 6.45 (1H, s, H-6),
6.19 (1H, s, H-8). 13C-NMR (500 MHz, DMSO-d6): δ
(ppm) = 94.4 [Glucose (G)1], 73.3 (G2), 72.3 (G3), 77.3
(G4), 72.4 (G5), 60.3 (G6), 99.3 [Rhamnose (R)1], 77.2
(R2), 77.0 (R3), 76.4 (R4), 71.9 (R5), 18.1 (R6).
Compound B – 1H-NMR (500 MHz, DMSO-d6): δ
(ppm) = 13.14 (1H, s, 5-OH), 7.55 (1H, d, J = 8.5 Hz,
H-6′), 7.49 (1H, s, H-2′), 6.87 (1H, d, J = 8.4 Hz, H-5′),
6.66 (1H, s, H-3), 6.26 (1H, s, H-6), 4.98 (1H, s,
H-1 Rha), 4.75 (1H, d, J = 9.9 Hz, H-1 Glc). After
hydrolysis: δ (ppm) 7.54 (1H, d, J = 8.4, H-6′), 7.48 (1H,
s, H-2′), 6.87 (1H, d, J = 8.4 Hz, H-5′), 6.65 (1H, s, H-
3), 6.27 (1H, s, H-6), 4.67 (1H, d, J = 9.0, H-1 Glc). 13C-
NMR (500 MHz, DMSO-d6): δ (ppm) = 71.5 (G1), 75.1
(G2), 80.0 (G3), 70.4 (G4), 82.0 (G5), 61.5 (G6), 100.4
(R1), 70.9 (R2), 70.5 (R3), 71.7 (R4), 68.3 (R5), 17.8
(R6).
Pharmacological studies
When testing the infusion and TFF to determine the
most suitable time-course for the observation of the
behavioural effects (Table 1), positive results were found
(i.e. statistical significant differences with relation to
groups administered only with vehicle-distilled water)
were observed after 60 min of the oral administration.
After 90 min, the results were less significant and after
120 min there was a general increase in the dispersion
of the results. Therefore, all other results presented in
this paper were obtained 60 min after oral administra-
tion of all test solutions.
For the lyophilized infusion doses were tested be-
tween 5 and 230 mg/kg. Only the highest dose (230 mg/
kg) produced a statistical significant increase in both
the percentage of time spent and the number of entries
into the open arms of the EPM in relation to the group
administered with vehicle (Fig. 2). Also, in the MBT
there was a significant diminution of the object-burying
reflex only at the highest dose (230 mg/kg; Fig. 3). In
the range of doses tested for the infusion there were no
significant changes in the parameters evaluated in the
wire and chimney tests (Fig. 4).
For TFF doses between 1 and 100 mg/kg were tested.
For the dose corresponding to the active dose of the
infusion (3.2 mg/kg) there were no significant changes
in any of the tests. However, with 100 mg/kg there was
an increase in the percentage of entries and the time
spent in the open arms of the EPM (Fig. 2). Results of
the horizontal wire test showed an increase in the
percentage of animals considered to be under muscle
Figure 2. Analysis of the behaviour of mice in the elevated plus maze test of anxiety. Results expressed as average (± SEM)
percentage of entries in the open areas of the maze (closed bars) and average percentage of time in the open areas of the maze
(hatched bars). *** p < 0.001; ** p < 0.01; * p < 0.05 are significantly different from control (ANOVA; Tukey’s test). The number of
mice per group ranged between 9 and 16.
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Figure 3. Behavior of mice in the marble burying test. Results
expressed as average percentage (± SEM) of buried marbles.
*** p < 0.001; ** p < 0.01; * p < 0.05 are significantly different
from control (ANOVA; Tukey’s test). The number of mice per
group ranged between 8 and 11.
With compounds A (0.3–30 mg/kg) and B (0.7–
100 mg/kg), isolated from SF I, only A (30 mg/kg)
significantly increased the percentage of time spent in
the open arms of the EPM (Fig. 2) and none of them
induced any effects on the motor activity tests (Fig. 4).
Analysis of the ethological parameters in the EPM
was performed only for SF I, II, III and compounds A
and B (Table 2). The only significant differences were
found for SF I and compound A. SF I decreased the
number of total stretch approach postures (SAP) with
50 and 100 mg/kg, whereas it also increased the total
number of head-dippings. Compound A (30 mg/kg)
significantly increased the number of head-dips.
DISCUSSION
The elevated plus-maze is now widely accepted as an
animal model of anxiety (Reibaud and Böhme, 1993).
The ratio of the number of entries into the open arms
to the total number of arm entries and the ratio of
the time spent in the open arms to the time spent in
both types of arms are used as markers of the natural
aversion of rodents for the open arms and these two
parameters have been shown to be increased by clini-
cally effective anxiolytics and to be decreased by
anxiogenic drugs (Lister, 1987; Pellow et al., 1985). The
defensive burying is a behaviour that can be elicited in
rodents in response to aversive stimuli and inhibited by
diazepam or chlordiazepoxide (Treit et al., 1981). Glass
marbles provide an effective unconditioned stimulus
relaxant effects and an increase in the percentage of
animals presenting motor uncoordination in the chim-
ney test (Fig. 4). With both 50 and 100 mg/kg a reduc-
tion of the marble-burying reflex was observed (Fig. 3).
With SF I, II and III there were no positive results in
any of the tests when a dose corresponding to the ac-
tive dose of TFF (100 mg/kg) was used. But when higher
doses were tested, SF I significantly increased the time
spent (100 mg/kg) and the number of entries (50 and
100 mg/kg) in the open arms of the plus-maze (Fig. 2),
without any effect on motor activity parameters
(Fig. 4). SF II (10–100 mg/kg) and SF III (1–100 mg/kg)
induced no significant changes in any of the tests used.
Figure 4. Performance of mice in the horizontal-wire and in the chimney test: mice who failed to grasp the wire with their hind paws
in 5 s were considered to be under a myorelaxant effect and those who failed to climb the chimney backwards in 30 s were
considered to be motor uncoordinated. * p < 0.001 significantly different from control, Fisher’s exact test. The number of mice per
group ranged between 11 and 16.
Table 2. Analysis of ethological parameters in the EPM
Protected Total stretched
head-dips (%) attend postures
Vehicle (n = 13) 72.1/6.7 16.2/3.8
Diazepam (1 mg/kg) (n = 11) 50.1/11.2b 6.8/2.1b
SF I (100 mg/kg) (n = 10) 60.3/5.4a 6.4/2.5b
SF I (50 mg/kg) (n = 9) 68.2/7.3 7.3/5.7a
A (30 mg/kg) (n = 9) 58.6/6.5a 17.3/8.0
B (70 mg/kg) (n = 10) 70.1/9.2 18.4/7.1
Data presented as mean/SEM. Statistical analysis a p < 0.05; b p < 0.001 with
ANOVA and Tukey’s test.
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motor activity measured in the EPM and by the chim-
ney and wire tests, hence indicating a specific anxiolytic-
like effect without sedation or muscle relaxation.
When both isolated components of SF I were tested
it was verified that only compound A (30 mg/kg) in-
duced changes in both classical and ethological derived
parameters of the EPM, consistent with an anxiolytic-
like effect which in this case correlated very well with
its content in the active dose of SF I (100 mg/kg).
1H-NMR analysis of SF I isolated constituents, re-
vealed that both compound A and B, were substituted
flavones. Through the assignment of 13C-NMR signals
and from HMBC and COSY correlations, the type and
relative position of the sugar residues in the flavone
nucleus were established. The results were consistent
with the structure of luteolin-7-O-[2-rhamnosylglu-
coside] (compound A) and 8-C-glucosylluteolin-
2″-rhamnoside (compound B). This leads to the
conclusion that if the C-linked rhamnoglucosyl appears
in position 8 of the flavone nucleus this can negatively
affect the neuropharmacological activity.
Recently Dhawan et al. (2004) questioned the
correct identification of the Passiflora species used in
previous studies and attributed the discrepancy in the
literature to this fact. These authors also reported on a
comparison of P. incarnata L. with P. edulis Sims in the
elevated plus-maze test of anxiety concluding that P.
edulis Sims was devoid of pharmacological activity
(Dhawan et al., 2001). Although it is agreed that in
some cases there is a strong possibility of mistaken iden-
tity between P. incarnata L. and P. edulis Sims due to
their morphological resemblance, it is not believed that
this assumption can be used to simply rule out all the
anxiolytic-like activity reports of other Passifloraceae.
Instead it is believed that the apparent discrepancy
between our results and those of Dhawan is surely a
consequence of the differences in the chemical compo-
sition of the plant extracts used, maybe originating in
the processing and extraction procedures of the botani-
cal materials or even in the different P. edulis Sims
chemotypes used by each group.
Although we did not identify all the active constitu-
ents in P. edulis Sims and our results cannot be used to
justify the medicinal use of this plant, this study clearly
demonstrated that this plant’s aqueous extracts and
flavonoids did have anxiolytic-like activity and that
at least one of these flavonoids, luteolin-7-O-[2-
rhamnosylglucoside], can elicit the same kind of
neuropharmacological activity.
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which provokes burying (Poling et al., 1981) and this
model has been used for the screening of anxiolytic-
like drugs with the diminution of the burying activity
indicating an anxiolytic-like effect (Broekkamp et al.,
1986). Therefore the results obtained with P. edulis Sims
infusions in the EPM and MBT are consistent with an
anxiolytic-like effect. As there were no significant
changes on the motor activity parameters measured by
the wire and the chimney tests it was concluded that
this anxiolytic-like effect was devoid of any effects on
motor activity.
TFF also revealed an anxiolytic-like activity in both
EPM and MBT parameters but unlike the infusion and
despite the number of entries into the enclosed arms
of the EPM [parameter directly related with motor
activity (Rodgers and Cole, 1994)] remaining
unchanged, the results obtained in the wire and in the
chimney tests indicate muscle relaxant effects with
motor impairment. As TFF is mainly composed of
flavonoids and tested negatively for other possible
active substances, such as tannins or alkaloids
(Takahashi et al., 1986; Aoagy et al., 1974), it was
concluded that the flavonoids extracted from P. edulis
Sims could be involved in the neuropharmacological
activity. However, as the doses (50 and 100 mg/kg) neces-
sary to induce positive effects were much higher than
the TFF content in the active dose of the infusion and
the pharmacological profile was also different a possi-
ble direct or indirect involvement of other compounds
in the activity of the infusion cannot be ruled out.
Ethological derived parameters such as protected
head-dipping or stretched attend postures are risk
assessment measures inversely related with an anxiolytic
effect and are generally more sensitive to drug action
than the traditional indices of anxiety in this test
(Rodgers and Cole, 1994). Hence it can be concluded
that the SF I (50, 100 mg/kg) increase in the conven-
tional spatiotemporal parameters of open arms explo-
ration and decrease of head-dipping and stretched
attend postures is consistent with an anxiolytic-like
effect. However, SF I did not have any effect on MBT
which can be described as a model of novelty-induced
or proximal threat anxiety, whereas EPM is a model of
approach-avoidance conflict. It is known that the same
compound may act at different dose ranges in distinct
models (Olivier et al., 2000), however, the differences
obtained spanned all the dose ranges tested and this
aspect should be further investigated.
The positive results of SF I obtained in the EPM
were observed for doses much higher than the corres-
ponding dose of the active extract from which it was
obtained thus suggesting that other compounds in TFF
could also be involved in its neuropharmacological
activity. The same doses did not elicit any effect on the
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